Find information on thousands of medical conditions and prescription drugs.

Sheehan syndrome

Sheehan syndrome, also known as Simmond's disease, postpartum hypopituitarism or postpartum pituitary necrosis is hypopituitarism (decreased functioning of the pituitary gland), caused by necrosis due to blood loss and hypovolemic shock during and after childbirth. It is a rare complication of pregnancy, usually occurring after excessive blood loss; the presence of disseminated intravascular coagulation (e.g. in amniotic fluid embolism or HELLP syndrome) also appears to be a factor in its development.

Home
Diseases
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
Sabinas brittle hair...
Saccharopinuria
Sacral agenesis
Saethre-Chotzen syndrome
Salla disease
Salmonellosis
Sandhoff disease
Sanfilippo syndrome
Sarcoidosis
Say Meyer syndrome
Scabies
Scabiophobia
Scarlet fever
Schamberg disease...
Schistosomiasis
Schizencephaly
Schizophrenia
Schmitt Gillenwater Kelly...
Sciatica
Scimitar syndrome
Sciophobia
Scleroderma
Scrapie
Scurvy
Selachophobia
Selective mutism
Seminoma
Sensorineural hearing loss
Seplophobia
Sepsis
Septo-optic dysplasia
Serum sickness
Severe acute respiratory...
Severe combined...
Sezary syndrome
Sheehan syndrome
Shigellosis
Shingles
Shock
Short bowel syndrome
Short QT syndrome
Shprintzen syndrome
Shulman-Upshaw syndrome
Shwachman syndrome
Shwachman-Diamond syndrome
Shy-Drager syndrome
Sialidosis
Sickle-cell disease
Sickle-cell disease
Sickle-cell disease
Siderosis
Silicosis
Silver-Russell dwarfism
Sipple syndrome
Sirenomelia
Sjogren's syndrome
Sly syndrome
Smallpox
Smith-Magenis Syndrome
Sociophobia
Soft tissue sarcoma
Somniphobia
Sotos syndrome
Spasmodic dysphonia
Spasmodic torticollis
Spherocytosis
Sphingolipidosis
Spinal cord injury
Spinal muscular atrophy
Spinal shock
Spinal stenosis
Spinocerebellar ataxia
Splenic-flexure syndrome
Splenomegaly
Spondylitis
Spondyloepiphyseal...
Spondylometaphyseal...
Sporotrichosis
Squamous cell carcinoma
St. Anthony's fire
Stein-Leventhal syndrome
Stevens-Johnson syndrome
Stickler syndrome
Stiff man syndrome
Still's disease
Stomach cancer
Stomatitis
Strabismus
Strep throat
Strongyloidiasis
Strumpell-lorrain disease
Sturge-Weber syndrome
Subacute sclerosing...
Sudden infant death syndrome
Sugarman syndrome
Sweet syndrome
Swimmer's ear
Swyer syndrome
Sydenham's chorea
Syncope
Syndactyly
Syndrome X
Synovial osteochondromatosis
Synovial sarcoma
Synovitis
Syphilis
Syringomas
Syringomyelia
Systemic carnitine...
Systemic lupus erythematosus
Systemic mastocytosis
Systemic sclerosis
T
U
V
W
X
Y
Z
Medicines

Read more at Wikipedia.org


[List your site here Free!]


Pathologic Quiz Case: A 27-Year-Old Man With Abdominal Pain
From Archives of Pathology & Laboratory Medicine, 4/1/04 by Boyanton, Bobby L Jr

A 27-year-old man presented to the emergency department with a 3-day history of progressively worsening abdominal pain, nausea, emesis, and obstipation following a weekend drinking binge. The patient's medical history was significant for smoking and alcohol abuse. Family history was significant for "intestinal problems" in 2 uncles. Physical examination revealed an afebrile patient with epigastric pain and high-pitched bowel sounds. Results of laboratory tests were within normal limits, except for an amylase level of 254 U/L (reference range, 25-115 U/L), and a mildly elevated white blood cell count of 13000/µL (reference range, 4000-11000/µL). A computed tomographic scan with oral contrast demonstrated multiple pedunculated intraluminal masses (Figure 1, red arrows) throughout the small intestine and jejunojejunal intussusception (Figure 1, black arrows).

Surgical intervention consisted of partial jejunectomy with primary anastomosis after failed attempts at reduction; enterotomy removed the remaining palpable masses from the small intestine. Pathologic inspection of the ischemic segment of resected jejunum revealed 5 cerebriform-like polyps ranging from 0.5 to 4.5 cm, the largest of which served as the lead point of intussusception. Enterotomy produced 4 additional cerebriform-like polyps ranging from 0.5 to 2.5 cm; 3 of these polyps were near the ligament of Treitz, and 1 was in the distal ileum.

Hematoxylin-eosin-stained sections confirmed ischemic necrosis of the resected jejunum. The polyps demonstrated a core of smooth muscle arising from the muscularis mucosae with extensive "treelike" branching, lined by normal small bowel epithelium (Figures 2 and 3). The smooth muscle component was verified by immunohistochemical staining for smooth muscle actin (Figure 4).

What is your diagnosis?

Pathologic Diagnosis: Peutz-Jeghers Syndrome

Peutz-Jeghers syndrome is a rare autosomal dominant condition characterized by gastrointestinal polyps, mucocutaneous hyperpigmentation, and an increased risk of gastrointestinal and extraintestinal carcinoma. The original link between hyperpigmentation and gastrointestinal polyposis was described by Peutz in 1921(1); however, it was not until 1949 that Jeghers associated those clinical findings with the risk of invasive carcinoma.2

Patients with Peutz-Jeghers syndrome usually present in their 20s with sequelae of gastrointestinal polyposis, including abdominal pain, obstruction, intussusception, or bleeding.3 The polyps, primarily located in the small bowel with a predilection for the jejunum,3 may be found throughout the entire gastrointestinal tract.4 Mucocutaneous hyperpigmentation invariably involves the perioral region and buccal mucosa, and less commonly the genitalia, hands, or feet.3,4 Rarely, pigmentation fails to develop, leading to delays in diagnosis and appropriate management, especially when a family history of the syndrome is absent. The diagnosis of Peutz-Jeghers syndrome is made by histologic verification of characteristic hamartomatous polyps and 2 of the following: small bowel polyposis, mucocutaneous pigmentation, and a family history of the syndrome.5

Histologically, the hamartomatous polyps exhibit a smooth muscle core arising from the muscularis mucosae, which branches into the polyp in a treelike or arborizing pattern, lined by epithelium native to the area of involvement.6 Approximately 10% of polyps will demonstrate the diagnostic pitfall of "pseudoinvasion," whereby epithelium is ectopically displaced into the submucosa, muscularis propria, or subserosa through defects in the bowel wall during episodes of elevated mechanical pressure, such as obstruction or intussusception,6 thereby mimicking invasive carcinoma. However, the absence of dysplastic epithelium, a stromal desmoplastic response, and mitoses strongly suggests pseudoinvasion and not invasive carcinoma.3,6

Patients with Peutz-Jeghers syndrome have an estimated 10- to 18-fold increased relative risk for the development of cancer compared to the general population.5,7 Two long-term independent studies following 65 patients with Peutz-Jeghers syndrome demonstrated the development of cancer in roughly 50% of patients, with the mean age of cancer onset at 40 years and a 20-year mean interval between the diagnosis of Peutz-Jeghers syndrome and cancer development.5,7 Gastrointestinal cancers (in decreasing order of frequency) involved the colon, duodenum, stomach, and esophagus.7 Extraintestinal cancers involved the breast (usually bilateral), lung, cervix, uterus, and thyroid.7 Additional neoplasms associated with this syndrome are mucinous ovarian cystadenofibromas, Sertoli-Leydig cell stromal tumors, pancreatic cancer, and sexcord tumors with annular tubules.4,7

Molecular linkage analysis has shown genetic alterations in the LKB1/STK11 gene (19p13.3), the product of which is a serine-threonine kinase involved in cellular signal transduction, to be the pathologic etiology in roughly 50% to 75% of cases.3,8-10 However, a second locus was recently mapped to 19p13.4, providing evidence for genetic heterogeneity in the Peutz-Jeghers syndrome.10

In summary, Peutz-Jeghers syndrome is an uncommon condition with profound clinical sequelae. By unraveling the complex inheritance of this syndrome, molecular analysis will not only be an invaluable tool for disease verification, but will provide a vital role in screening and early detection of patients with a family history of the syndrome, thereby permitting appropriate therapeutic intervention.

References

1. Peutz JLA. Very remarkable case of familial polyposis of mucous membrane of intestinal tract and nasopharynx accompanied by peculiar pigmentation of skin and mucous membrane. Ned Maandschr Geneeskd. 1921;10:134-146.

2. Jeghers H, MCKUSIC VA, Katz KH. Generalized intestinal polyposis and melanin spots of the oral mucosa, lips, and digits: a syndrome of diagnostic significance. N Engl J Med. 1949;241:993-1005.

3. Wirtzfeld DA, Petrelli NJ, Rodriquez-Bigas MA. Hamartomatous polyposis syndromes: molecular genetics, neoplastic risk, and surveillance recommendations. Ann Surg Oncol. 2001;8:319-327.

4. Spigelman AD, Arese P, Phillips RK. Polyposis: the Peutz-Jeghers syndrome. Br J Surg. 1995:82:1311-1314.

5. Giardiello FM, Welsh SB, Hamilton SR, et al. Increased risk of cancer in the Peutz-Jeghers syndrome. N Engl J Med. 1987:316:1511-1514.

6. Petersen VC, Sheehan AL, Bryan RL, Armstrong CP, Shepard NA. Misplacement of dysplastic epithelium in Peutz-Jeghers polyps: the ultimate diagnostic pitfall? Am J Surg Pathol. 2000;24:34-39.

7. Boardman LA, Thibodeau SN, Schaid DJ, et al. Increased risk for cancer in patients with the Peutz-Jeghers syndrome. Ann Intern Med. 1998;128:896-899.

8. Wang Z-J, Churchman M, Avizienyte E, et al. Germline mutations of the LKB1 (STK11) gene in Peutz-Jeghers patients. J Med Genet. 1999:36:365-368.

9. Olschwang S, Markie D, Seal S, et al. Peutz-Jeghers disease: most, but not all, families are compatible with linkage to 19p13.3. J Med Genet. 1998:35:42-44.

10. Mehenni H, Blouin JL, Radhakrishna U, et al. Peutz-Jeghers syndrome: confirmation of linkage to chromosome 19p13.3 and identification of a potential second locus, on 19p13.4. Am J Hum Genet. 1997:61:1327-1334.

Bobby L. Boyanton, Jr, MD, MT(ASCP); Stephen S. Shinault, DO

Accepted for publication November 24, 2003.

From the Departments of Pathology (Dr Boyanton) and Radiological Sciences (Dr Shinault), University of Oklahoma Health Science Center, Oklahoma City. Dr Boyanton is now with the Department of Pathology, Baylor College of Medicine, Houston, Tex.

The authors have no relevant financial interest in the products or companies described in this article.

Corresponding author: Bobby L. Boyanton, Jr, MD, MT(ASCP), Department of Pathology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030-3498 (e-mail: boyanton@bcm.tmc.edu).

Reprints not available from the authors.

Copyright College of American Pathologists Apr 2004
Provided by ProQuest Information and Learning Company. All rights Reserved

Return to Sheehan syndrome
Home Contact Resources Exchange Links ebay